What is PranaX?
PranaX is an innovative health science company headquartered in Houston, Texas, dedicated to pioneering longevity solutions and improving quality of life via regenerative science. The firm specializes in exosome-based regenerative wellness, aiming to combat the health challenges associated with an aging global population. By focusing on advanced biotechnology, PranaX empowers individuals to proactively manage their health, with strategic initiatives including the licensing of exosome technology and furthering the understanding of healthspan versus lifespan.
How much funding has PranaX raised?
PranaX has raised a total of $17M across 1 funding round:
Series A
$17M
Series A (2026): $17M, investors not publicly disclosed
What's next for PranaX?
With its recent major strategic investment, PranaX is poised for significant expansion and further development of its regenerative wellness platforms. The enterprise-level funding context suggests a focus on scaling operations, advancing clinical research, and potentially broadening market reach. This capital infusion will likely accelerate PranaX's efforts to commercialize its exosome-based technologies, solidifying its position in the competitive health science and longevity market. The company's strategic direction points towards continued innovation in addressing age-related health concerns.
See full PranaX company page
